Ranibizumab is a High-Purity Anti-VEGF Biologic for Ophthalmic Applications
Bulk production capacity for commercial and research needs
Available in various concentrations & formulations as per client requirements
Produced under internationally recognized Good Manufacturing Practices (GMP)
Product application
• Age-Related Macular Degeneration (AMD) • Diabetic Macular Edema (DME) • Retinal Vein Occlusion (RVO)
Connect to Explore More
High-Purity Anti-VEGF Biologic for Ophthalmic Applications Ranibizumab is a recombinant, humanized monoclonal antibody fragment (Fab) that specifically inhibits vascular endothelial growth factor A (VEGF-A). It is widely used in the treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and other retinal vascular diseases.
Why Choose us?
Advanced bioprocessing technology ensuring high yield & purity
Expertise in monoclonal antibody fragment production Available in bulk quantities to meet pharmaceutical needs.
End-to-end regulatory & technical support
Key features & Benefits
• High Purity & Quality – Manufactured using state-of-the-art peptide synthesis technology.
• GMP Compliance Production – Adheres to stringent Good Manufacturing Practices.
• Customized Solutions – Available in bulk quantities to meet pharmaceutical needs.
• Global Supply & Compliance – Compliant with international pharmacopeial standards.
Specifications
• Molecular Weight: ~48 kDa
• Expression System: CHO (Chinese Hamster Ovary) cells
• Purity: ≥ 98% (by HPLC/SEC)
• Formulation: Lyophilized powder / Liquid solution
• Storage Conditions: -20°C to -80°C
Regulatory Support
• Advanced bioprocessing technology ensuring high yield & purity
• Expertise in monoclonal antibody fragment production
• End-to-end regulatory & technical support
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.
Ranibizumab is a High-Purity Anti-VEGF Biologic for Ophthalmic Applications
Bulk production capacity for commercial and research needs
Available in various concentrations & formulations as per client requirements
Produced under internationally recognized Good Manufacturing Practices (GMP)
Product application
• Age-Related Macular Degeneration (AMD) • Diabetic Macular Edema (DME) • Retinal Vein Occlusion (RVO)
Connect to Explore More
High-Purity Anti-VEGF Biologic for Ophthalmic Applications Ranibizumab is a recombinant, humanized monoclonal antibody fragment (Fab) that specifically inhibits vascular endothelial growth factor A (VEGF-A). It is widely used in the treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and other retinal vascular diseases.
Why Choose us?
Advanced bioprocessing technology ensuring high yield & purity
Expertise in monoclonal antibody fragment production Available in bulk quantities to meet pharmaceutical needs.
End-to-end regulatory & technical support
Key features & Benefits
• High Purity & Quality – Manufactured using state-of-the-art peptide synthesis technology.
• GMP Compliance Production – Adheres to stringent Good Manufacturing Practices.
• Customized Solutions – Available in bulk quantities to meet pharmaceutical needs.
• Global Supply & Compliance – Compliant with international pharmacopeial standards.
Specifications
• Molecular Weight: ~48 kDa
• Expression System: CHO (Chinese Hamster Ovary) cells
• Purity: ≥ 98% (by HPLC/SEC)
• Formulation: Lyophilized powder / Liquid solution
• Storage Conditions: -20°C to -80°C
Regulatory Support
• Advanced bioprocessing technology ensuring high yield & purity
• Expertise in monoclonal antibody fragment production
• End-to-end regulatory & technical support
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.
Ranibizumab is a High-Purity Anti-VEGF Biologic for Ophthalmic Applications
Bulk production capacity for commercial and research needs
Available in various concentrations & formulations as per client requirements
Produced under internationally recognized Good Manufacturing Practices (GMP)
Product application
• Age-Related Macular Degeneration (AMD) • Diabetic Macular Edema (DME) • Retinal Vein Occlusion (RVO)
Connect to Explore More
High-Purity Anti-VEGF Biologic for Ophthalmic Applications Ranibizumab is a recombinant, humanized monoclonal antibody fragment (Fab) that specifically inhibits vascular endothelial growth factor A (VEGF-A). It is widely used in the treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and other retinal vascular diseases.
Why Choose us?
Advanced bioprocessing technology ensuring high yield & purity
Expertise in monoclonal antibody fragment production Available in bulk quantities to meet pharmaceutical needs.
End-to-end regulatory & technical support
Key features & Benefits
• High Purity & Quality – Manufactured using state-of-the-art peptide synthesis technology.
• GMP Compliance Production – Adheres to stringent Good Manufacturing Practices.
• Customized Solutions – Available in bulk quantities to meet pharmaceutical needs.
• Global Supply & Compliance – Compliant with international pharmacopeial standards.
Specifications
• Molecular Weight: ~48 kDa
• Expression System: CHO (Chinese Hamster Ovary) cells
• Purity: ≥ 98% (by HPLC/SEC)
• Formulation: Lyophilized powder / Liquid solution
• Storage Conditions: -20°C to -80°C
Regulatory Support
• Advanced bioprocessing technology ensuring high yield & purity
• Expertise in monoclonal antibody fragment production
• End-to-end regulatory & technical support
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.